DK0535645T3 - Carbamatderivater af 4-amino-3-isoxazolidinoner og 3-amino-1-hydroxypyrrolidin-2-oner, fremgangsmåde til deres fremstilling samt deres anvendelse som lægemidler - Google Patents

Carbamatderivater af 4-amino-3-isoxazolidinoner og 3-amino-1-hydroxypyrrolidin-2-oner, fremgangsmåde til deres fremstilling samt deres anvendelse som lægemidler

Info

Publication number
DK0535645T3
DK0535645T3 DK92116760T DK92116760T DK0535645T3 DK 0535645 T3 DK0535645 T3 DK 0535645T3 DK 92116760 T DK92116760 T DK 92116760T DK 92116760 T DK92116760 T DK 92116760T DK 0535645 T3 DK0535645 T3 DK 0535645T3
Authority
DK
Denmark
Prior art keywords
amino
preparation
isoxazolidinones
hydroxypyrrolidin
ones
Prior art date
Application number
DK92116760T
Other languages
English (en)
Inventor
Denise Mary Flanagan
Lawrence Leo Martin
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Application granted granted Critical
Publication of DK0535645T3 publication Critical patent/DK0535645T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Psychiatry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
  • Fats And Perfumes (AREA)
DK92116760T 1991-10-01 1992-09-30 Carbamatderivater af 4-amino-3-isoxazolidinoner og 3-amino-1-hydroxypyrrolidin-2-oner, fremgangsmåde til deres fremstilling samt deres anvendelse som lægemidler DK0535645T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/769,268 US5153193A (en) 1991-10-01 1991-10-01 Carbamate derivatives of 4-amino-3-isoxazolidinones, 3-amino-1-hydroxypyrrolidin-2-ones and 1-amino-1-cyclopropanecarboxylic acid analogs

Publications (1)

Publication Number Publication Date
DK0535645T3 true DK0535645T3 (da) 2001-08-13

Family

ID=25084962

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92116760T DK0535645T3 (da) 1991-10-01 1992-09-30 Carbamatderivater af 4-amino-3-isoxazolidinoner og 3-amino-1-hydroxypyrrolidin-2-oner, fremgangsmåde til deres fremstilling samt deres anvendelse som lægemidler

Country Status (21)

Country Link
US (1) US5153193A (da)
EP (2) EP0535645B1 (da)
JP (1) JP2703157B2 (da)
KR (2) KR100276143B1 (da)
AT (1) ATE201024T1 (da)
AU (1) AU649882B2 (da)
CA (1) CA2079548C (da)
CZ (1) CZ281982B6 (da)
DE (1) DE69231817T2 (da)
DK (1) DK0535645T3 (da)
ES (1) ES2157201T3 (da)
FI (2) FI102178B1 (da)
GR (1) GR3036334T3 (da)
HU (1) HU215120B (da)
IL (1) IL103304A (da)
MX (1) MX9205577A (da)
NO (1) NO301884B1 (da)
NZ (1) NZ244540A (da)
PT (1) PT535645E (da)
RU (1) RU2103271C1 (da)
TW (1) TW208009B (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5231093A (en) * 1991-10-01 1993-07-27 Hoechst-Roussel Pharmaceuticals Incorporated Carbamate derivatives of 4-amino-3-isoxazolidinones, 3-amino-1-hydroxypyrrolidin-2-ones and 1-amino-1-cyclopropanecarboxylic acid analogs
IT1253007B (it) * 1991-12-31 1995-07-10 Aesculapius Farma Srl Derivati dell'eserolina ad attivita' anticolinesterasica,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
US5480651A (en) * 1992-03-16 1996-01-02 Regents Of The University Of California Composition and method for treating nicotine craving in smoking cessation
US6316439B1 (en) 1993-10-15 2001-11-13 Aventis Pharamaceuticals Inc. Galanthamine derivatives as acetylcholinesterase inhibitors
US6323195B1 (en) * 1993-10-15 2001-11-27 Aventis Pharmaceuticals Inc. Galanthamine derivatives as acetylcholinesterase inhibitors
US6323196B1 (en) * 1993-10-15 2001-11-27 Aventis Pharmaceuticals Inc. Galanthamine derivatives as acetylcholinesterase inhibitors
AT403803B (de) * 1996-04-19 1998-05-25 Sanochemia Ltd Neue benzazepinderivate, diese enthaltende arzneimittel und verwendung derselben zum herstellen von arzneimitteln
US5665880A (en) * 1996-10-31 1997-09-09 Hoechst Marion Roussel, Inc. Method of preparation of physostigmine carbamate derivatives from eseretholes
US5677457A (en) * 1996-12-19 1997-10-14 Hoechst Marion Roussel, Inc. Method of preparation of physostigmine carbamate derivatives from eseroline ethers
WO2000059544A1 (fr) * 1999-03-31 2000-10-12 Eisai Co., Ltd. Compositions stabilisees contenant des medicaments nootropes
DE50101827D1 (de) * 2000-03-31 2004-05-06 Sanochemia Pharmazeutika Ag Wi Neue derivate und analoga von galanthamin
AU2001217709B2 (en) * 2000-11-16 2005-10-13 Alcon Manufacturing, Ltd. Combination therapy for lowering and controlling intraocular pressure
WO2005042475A2 (en) * 2003-10-21 2005-05-12 Sention, Inc. Carbamoyl esters that inhibit cholinesterase and release pharmacologically active agents
US7549431B1 (en) * 2004-11-10 2009-06-23 Gore Enterprise Holdings, Inc. Protective enclosure
TWI487486B (zh) 2009-12-01 2015-06-11 Syngenta Participations Ag 以異唑啉衍生物為主之殺蟲化合物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1974782U (de) 1967-07-04 1967-12-14 Filzfabrik Fulda G M B H & Co Matratzenschoner.
US4791107A (en) * 1986-07-16 1988-12-13 Hoechst-Roussel Pharmaceuticals, Inc. Memory enhancing and analgesic 1,2,3,3A,8,8A-hexahydro-3A,8 (and) 1,3A,8)-di(and tri)methylpyrrolo(2,3-B)indoles, compositions and use
DE3856594D1 (de) * 1987-05-04 2008-11-27 Bonnie Davis Mittel zur behandlung der alzheimer-krankheit
GB8727792D0 (en) * 1987-11-27 1987-12-31 Merck Sharp & Dohme Therapeutic agents
GB8823605D0 (en) * 1988-10-07 1988-11-16 Merck Sharp & Dohme Therapeutic agents
US5187171A (en) * 1989-01-09 1993-02-16 G. D. Searle & Co. Use of a glycine b partial agonist as an antipsychotic
US5061721A (en) * 1989-03-15 1991-10-29 G. D. Searle & Co. Composition containing d-cycloserine and d-alanine for memory and learning enhancement or treatment of a cognitive or psychotic disorder
US4914102A (en) * 1989-09-28 1990-04-03 Hoechst Roussel Pharmaceuticals, Inc. N-aminocarbamates related to physostigmine, pharmacentical compositions and use

Also Published As

Publication number Publication date
EP0535645A2 (en) 1993-04-07
HUT65277A (en) 1994-05-02
ES2157201T3 (es) 2001-08-16
FI981710A0 (fi) 1998-08-06
HU9203129D0 (en) 1992-12-28
FI924370A0 (fi) 1992-09-29
NO923803D0 (no) 1992-09-30
EP1069125A2 (en) 2001-01-17
RU2103271C1 (ru) 1998-01-27
IL103304A (en) 1996-12-05
JP2703157B2 (ja) 1998-01-26
FI102178B (fi) 1998-10-30
FI924370A (fi) 1993-04-02
EP0535645A3 (en) 1993-08-04
HU215120B (hu) 1998-09-28
KR100271416B1 (en) 2000-11-15
NO301884B1 (no) 1997-12-22
CA2079548A1 (en) 1993-04-02
GR3036334T3 (en) 2001-11-30
CZ299092A3 (en) 1993-10-13
ATE201024T1 (de) 2001-05-15
EP0535645B1 (en) 2001-05-09
KR100276143B1 (ko) 2001-03-02
JPH05194519A (ja) 1993-08-03
AU2606592A (en) 1993-04-08
FI102178B1 (fi) 1998-10-30
NZ244540A (en) 1995-04-27
FI981710A (fi) 1998-08-06
DE69231817D1 (de) 2001-06-13
DE69231817T2 (de) 2001-09-27
NO923803L (no) 1993-04-02
AU649882B2 (en) 1994-06-02
KR930007947A (ko) 1993-05-20
IL103304A0 (en) 1993-02-21
TW208009B (da) 1993-06-21
MX9205577A (es) 1993-04-01
CZ281982B6 (cs) 1997-04-16
PT535645E (pt) 2001-09-27
EP1069125A3 (en) 2001-10-10
US5153193A (en) 1992-10-06
CA2079548C (en) 2002-03-19

Similar Documents

Publication Publication Date Title
DK0535645T3 (da) Carbamatderivater af 4-amino-3-isoxazolidinoner og 3-amino-1-hydroxypyrrolidin-2-oner, fremgangsmåde til deres fremstilling samt deres anvendelse som lægemidler
DK0562956T3 (da) Hidtil ukendte naphthylalkylaminer, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
DK0580502T3 (da) 3-(hydroxybenzylidenyl)-indolin-2-oner og farmaceutiske sammensætninger indeholdende disse
DK0587499T3 (da) Benzopyranforbindelser, fremgangsmåde til deres fremstilling og deres anvendelse som cellebeskyttelsesmidler
NO943895L (no) Galantaminderivater, en fremgangsmåte for fremstilling samt deres anvendelse som medikamenter
DK0402752T3 (da) N-Heteroaryl-purin-6-aminer, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler
DK0553016T3 (da) Hidtil ukendte naphtalenamider og -sulfonamider, fremgangsmåder til deres fremstilling samt farmaceutiske midler indeholdende dem
DK0632026T3 (da) Alfa-aminosyrederivater, en fremgangsmåde til deres fremstilling og farmaceutiske sammensætninger, der indeholder dem
ES2068216T3 (es) Compuestos de tienotriazolodiazepina y usos farmaceuticos de los mismos.
DK148288D0 (da) N-phenethylaminoalkyl-benzamid-forbindelser, deres anvendelse til fremstilling af antiarrhythmia-laegemidler og farmaceutiske praeparater indeholdende forbindelserne
DK364386D0 (da) 1-alkyl-ergolinyl-thiourinstofderivater og fremgangsmaade til fremstilling deraf samt deres anvendelse
DK0632035T3 (da) Hidtil ukendte aminoalkylchromoner, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
DK0587048T3 (da) Heteroarenylpiperaziner, en fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler
DK0615755T3 (da) Anvendelse af tetrahydropyridinderivater til fremstilling af cardiobeskyttende lægemidler
ZA933942B (en) Pyrrolothienopyrazine compounds, processes for the preparation thereof and pharmaceutical compositions containing them